SCHEMBL19003641

SCHEMBL19003641

CCCC(CC)c1ccc(Cl)c(OC)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.42
ALDH1A1 P00352 4/20 0.42
MAPT P10636 2/20 0.42
TAS1R3 Q7RTX0 2/20 0.39
TAS1R1 Q7RTX1 2/20 0.39
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
USP2 O75604 1/20 0.37
POLB P06746 1/20 0.37
CYP2C9 P11712 1/20 0.37
HPGD P15428 1/20 0.37
ALOX12 P18054 1/20 0.37
MAPK1 P28482 1/20 0.37
CYP2C19 P33261 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
AKR1C3 P42330 1/20 0.37
AKR1C2 P52895 1/20 0.37
PDE4A P27815 2/20 0.36
PDE4B Q07343 2/20 0.36
PDE4C Q08493 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20289179 0.89 TAS1R3 (0.47) L3MBTL1ALDH1A1MAPTTAS1R3TAS1R1
SCHEMBL13045900 0.84 PPARG (0.49) L3MBTL1ALDH1A1MAPTMEN1KMT2A
SCHEMBL20372911 0.80 TAS1R3 (0.40) TAS1R3TAS1R1PDE4APDE4BPDE4C
SCHEMBL13933588 0.80 TAAR1 (0.40) MAPTTAS1R3TAS1R1MAPK1PDE4A
SCHEMBL21164366 0.79 S1PR1 (0.36)
SCHEMBL22932925 0.79 PPARG (0.50) L3MBTL1ALDH1A1MAPTMEN1KMT2A
SCHEMBL20921361 0.79 TAS1R3 (0.48) TAS1R3TAS1R1MEN1KMT2AMAPK1
SCHEMBL21164523 0.78 SLC6A4 (0.36) CYP2C9CYP2C19CYP3A4
SCHEMBL21164590 0.78 MAPT (0.42) L3MBTL1ALDH1A1MAPTMEN1KMT2A
SCHEMBL12646342 0.77 MEN1 (0.46) L3MBTL1ALDH1A1MAPTTAS1R3TAS1R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2938344-B1 PIPERAZINE-SUBSTITUTED [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINE COMPOUNDS WITH A2A ANTAGONIST PROPERTIES MERCK SHARP & DOHME (US) 2017-06-21 EP disclosed